NgBR inhibitors are a class of chemical compounds specifically formulated to target and inhibit the Nogo-B receptor (NgBR), a protein that has garnered significant interest in the field of cellular biology. NgBR is known to be involved in several crucial cellular processes, including lipid biosynthesis and the regulation of vascular and cellular homeostasis. It is identified as a specific receptor for Nogo-B, a member of the reticulon family of proteins, and plays a role in modulating the Nogo-B signaling pathway. The inhibitors of NgBR are designed to bind selectively to this receptor, thereby disrupting its interaction with Nogo-B and influencing the associated cellular pathways. The molecular structure of NgBR inhibitors typically features specific functional groups and moieties that enable effective binding to the NgBR protein. This design often includes a combination of hydrophobic and hydrophilic elements, aromatic rings, and hydrogen bond donors or acceptors, all carefully positioned to optimize interaction with NgBR and enhance the specificity and efficacy of inhibition.
The development of NgBR inhibitors is a sophisticated and multidisciplinary process, incorporating advanced techniques in chemical synthesis, structural biology, and computational modeling. Researchers employ methods such as X-ray crystallography and NMR spectroscopy to gain a detailed understanding of the structure of NgBR, focusing on its binding sites for inhibitors. This structural knowledge is essential for the rational design of molecules that can effectively target and bind to NgBR. In the realm of synthetic chemistry, various compounds are synthesized and tested for their ability to interact with NgBR. These compounds undergo iterative modifications to enhance their binding efficiency, specificity, and overall stability. Computational modeling plays a significant role in this development process, enabling the simulation of molecular interactions and aiding in the prediction of the binding affinity of inhibitors. Additionally, the physicochemical properties of NgBR inhibitors, such as solubility, stability, and bioavailability, are critical considerations. These properties are meticulously optimized to ensure that the inhibitors can effectively interact with NgBR and are suitable for use in various biological systems. The development of NgBR inhibitors exemplifies the intricate process of creating specific inhibitors to modulate the function of a targeted protein, showcasing the complex interplay between chemical structure and biological function.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits eukaryotic protein synthesis which may lead to a reduction in NgBR protein levels due to lack of new protein synthesis. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
By inhibiting RNA polymerase, it can reduce mRNA synthesis and potentially decrease NgBR expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Interacts with DNA and inhibits RNA synthesis, which could lead to decreased NgBR expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Inhibits RNA polymerase II and III, potentially reducing NgBR mRNA transcription. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
Causes premature chain termination during translation, possibly reducing overall protein levels, including NgBR. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor, which might indirectly affect NgBR expression by modulating downstream signaling pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor, potentially affecting the regulation of gene expression and NgBR levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR and could affect the stability and translation of NgBR mRNA. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
A flavonoid that can modulate multiple signaling pathways, potentially impacting NgBR transcription. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $352.00 $566.00 $1331.00 $2453.00 | ||
Inhibits eukaryotic protein synthesis and could decrease NgBR protein levels. | ||||||